Related Experiment Video
Updated: Feb 7, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Lipid profile and long-term outcome in premature myocardial infarction
Max-Paul Winter1, Franz Wiesbauer1, Hermann Blessberger2
1Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Insights
In premature myocardial infarction patients, non-HDL and remnant cholesterol levels predict long-term cardiovascular events. These lipid fractions, rather than LDL and HDL, are key indicators for risk stratification and treatment.
Area of Science:
- Cardiology
- Lipid Metabolism
- Preventive Medicine
Background:
- Premature myocardial infarction (MI) in individuals ≤40 years old has a unique risk factor profile, often involving elevated triglyceride-rich lipoproteins.
- Traditional lipid targets like high-density lipoprotein (HDL) and low-density lipoprotein (LDL) may be insufficient for assessing risk in younger MI patients.
- Familial combined hypercholesterolemia (FCH) is a prevalent phenotype in premature MI, characterized by combined elevations in multiple atherogenic lipoproteins.
Purpose of the Study:
- To evaluate the predictive capability of various lipid fractions for long-term cardiovascular outcomes in patients who have experienced premature MI.
- To assess the influence of the familial combined hypercholesterolemia phenotype and a multimarker lipid panel on cardiovascular outcomes in this cohort.
Main Methods:
- Prospective enrollment of 102 survivors of premature MI (≤40 years) across multiple centers.
- Analysis of lipid profiles, including total cholesterol, non-HDL cholesterol, remnant cholesterol, and Apo B lipoprotein.
- Investigation of the association between the familial combined hypercholesterolemia phenotype and cardiovascular events.
Main Results:
- Patients experiencing major adverse cardiovascular events (MACE) had significantly higher levels of total cholesterol, non-HDL cholesterol, remnant cholesterol, and Apo B.
- The familial combined hypercholesterolemia phenotype was independently associated with adverse cardiovascular outcomes (adjusted HR 3.04).
- Remnant cholesterol demonstrated the strongest association with MACE (adjusted HR 1.94), while LDL and HDL showed no significant impact.
Conclusions:
- Non-HDL cholesterol and remnant cholesterol are potent predictors of unfavorable outcomes in patients with premature MI.
- These lipid markers may serve as superior targets for lipid-lowering therapy in this specific patient population.
- Current risk stratification strategies focusing solely on LDL and HDL may need revision for premature MI.
Background:
Premature myocardial infarction (≤40 years) represents a rare disease with a distinct risk factor profile and a lipid phenotype that is characterized by a predominance of elevated triglyceride-rich lipoproteins. So far high-density and low-density lipoproteins remain the primary targets for risk stratification and treatment evaluation in coronary artery disease, but this strategy might be insensitive in patients with premature myocardial infarction.
Aim:
Aim of this study was to investigate the predictive value of different lipid fractions on long-term cardiovascular outcome in patients with premature myocardial infarction.
Methods:
We prospectively enrolled 102 consecutive AMI survivors (≤40 years) in this prospective multicentre study and investigated the influence of the familial combined hypercholesterolaemia phenotype and a corresponding multimarker panel of different lipid fractions on cardiovascular outcome.
Results:
Total cholesterol, non-HDL cholesterol, remnant cholesterol and Apo B lipoprotein were significantly higher in patients experiencing MACE as compared to those who did not. The familial combined hypercholesterolaemia phenotype was associated with an unfavourable cardiovascular outcome even after adjustment for potential cofounders (adjusted HR 3.04,95% CI, 1.26-7.34, P = 0.013). Remnant cholesterol revealed the strongest association with MACE (adj.HR 1.94, 95%CI. 1.30-2.99, P = 0.001). Interestingly LDL and HDL revealed no significant impact on cardiovascular outcome in this study cohort.
Conclusion:
Non-HDL and remnant cholesterol are strongly associated with an unfavourable outcome in patients with premature myocardial infarction and might be the preferred treatment target for lipid-lowering therapy.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
What are Lipids?
What are Lipids?
Non-Polar and Hydrophobic Characteristics of Lipids
Lipids are a structurally and functionally diverse group of hydrocarbons—compounds consisting of carbon and hydrogen atoms. The carbon-carbon and...
Lipid Digestion
Predicting Reaction Outcomes
Structure of Lipids

